CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Materialtyp: Artigo
Språk:Russo
Publicerad: IMA-PRESS LLC 2018-05-01
Serie:Научно-практическая ревматология
Ämnen:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Länkar:https://rsp.mediar-press.net/rsp/article/view/2524
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk